Pfizer reports positive top-line data from REFLECTIONS B538-02 study of PF-06410293
Pfizer has reported positive top-line data from its REFLECTIONS B538-02 study of PF-06410293 compared with Humira to treat moderate-to-severe rheumatoid arthritis (RA).
Source: Drug Development Technology - Category: Pharmaceuticals Source Type: news
More News: Arthritis | Humira | Pfizer | Pharmaceuticals | Rheumatoid Arthritis | Rheumatology | Study